Literature DB >> 17190601

The proteasome restricts permissive transcription at tissue-specific gene loci in embryonic stem cells.

Henrietta Szutorisz1, Andrew Georgiou, László Tora, Niall Dillon.   

Abstract

The ability of stem cells to activate different gene expression programs requires the choreographed assembly of trans-acting factors at enhancers and promoters during cell differentiation. In this study, we show that the proteasome acts on specific regulatory regions in embryonic stem (ES) cells to prevent incorrect transcriptional initiation. Chemical or siRNA-mediated inhibition of proteasome activity results in increased transcription factor and RNA polymerase II binding and leads to activation of cryptic promoters. Analysis of the binding profiles of different proteasome subunits in normal ES cells and following RNAi knockdown of individual subunits provides evidence for a targeted assembly of the 26S proteasome at specific regulatory elements. Our results suggest that the proteasome promotes a dynamic turnover of transcription factor and Pol II binding at tissue-specific gene domains in ES cells, thereby restricting permissive transcriptional activity and keeping the genes in a potentiated state, ready for activation at later stages.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17190601     DOI: 10.1016/j.cell.2006.10.045

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  64 in total

Review 1.  Ubiquitin and proteasomes in transcription.

Authors:  Fuqiang Geng; Sabine Wenzel; William P Tansey
Journal:  Annu Rev Biochem       Date:  2012-03-08       Impact factor: 23.643

2.  Similar temporal and spatial recruitment of native 19S and 20S proteasome subunits to transcriptionally active chromatin.

Authors:  Fuqiang Geng; William P Tansey
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

Review 3.  Dynamic changes in gene expression during human early embryo development: from fundamental aspects to clinical applications.

Authors:  Said Assou; Imène Boumela; Delphine Haouzi; Tal Anahory; Hervé Dechaud; John De Vos; Samir Hamamah
Journal:  Hum Reprod Update       Date:  2010-08-17       Impact factor: 15.610

4.  Repression of retrotransposal elements in mouse embryonic stem cells is primarily mediated by a DNA methylation-independent mechanism.

Authors:  Leah K Hutnick; Xinhua Huang; Tao-Chuan Loo; Zhicheng Ma; Guoping Fan
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

Review 5.  Emerging roles of the 26S proteasome in nuclear hormone receptor-regulated transcription.

Authors:  Brian R Keppler; Trevor K Archer; H Karimi Kinyamu
Journal:  Biochim Biophys Acta       Date:  2010-08-20

Review 6.  Intersection of nuclear receptors and the proteasome on the epigenetic landscape.

Authors:  H Karimi Kinyamu; Wendy N Jefferson; Trevor K Archer
Journal:  Environ Mol Mutagen       Date:  2008-01       Impact factor: 3.216

7.  Caspase activity mediates the differentiation of embryonic stem cells.

Authors:  Jun Fujita; Ana M Crane; Marlon K Souza; Marion Dejosez; Michael Kyba; Richard A Flavell; James A Thomson; Thomas P Zwaka
Journal:  Cell Stem Cell       Date:  2008-06-05       Impact factor: 24.633

8.  Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity.

Authors:  Premkumar Vummidi Giridhar; Karin Williams; Andrew P VonHandorf; Paul L Deford; Susan Kasper
Journal:  Cancer Res       Date:  2019-01-09       Impact factor: 12.701

9.  Global transcriptional repression in C. elegans germline precursors by regulated sequestration of TAF-4.

Authors:  Tugba Guven-Ozkan; Yuichi Nishi; Scott M Robertson; Rueyling Lin
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

10.  Bortezomib induces the formation of nuclear poly(A) RNA granules enriched in Sam68 and PABPN1 in sensory ganglia neurons.

Authors:  Iñigo Casafont; Maria T Berciano; Miguel Lafarga
Journal:  Neurotox Res       Date:  2009-07-16       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.